Hypoxia: the force that drives chronic kidney disease

Q Fu, SP Colgan, CS Shelley - Clinical medicine & research, 2016 - Marshfield Clinic
In the United States the prevalence of end-stage renal disease (ESRD) reached epidemic
proportions in 2012 with over 600,000 patients being treated. The rates of ESRD among the …

Hypoxia: The Force that Drives Chronic Kidney Disease

Q Fu, SP Colgan, CS Shelley - Clinical medicine & …, 2016 - pubmed.ncbi.nlm.nih.gov
In the United States the prevalence of end-stage renal disease (ESRD) reached epidemic
proportions in 2012 with over 600,000 patients being treated. The rates of ESRD among the …

[引用][C] Hypoxia: The Force that Drives Chronic Kidney Disease

Q Fu, SP Colgan, CS Shelley - Clinical Medicine & Research, 2016 - cir.nii.ac.jp
Hypoxia: The Force that Drives Chronic Kidney Disease | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …

Hypoxia: The Force that Drives Chronic Kidney Disease.

Q Fu, SP Colgan, CS Shelley - Clinical Medicine & Research, 2016 - europepmc.org
Abstract In the United States the prevalence of end-stage renal disease (ESRD) reached
epidemic proportions in 2012 with over 600,000 patients being treated. The rates of ESRD …

Hypoxia: The Force that Drives Chronic Kidney Disease

Q Fu, SP Colgan, CS Shelley - Clinical Medicine & Research, 2016 - Marshfield Clinic
Abstract In the United States the prevalence of end-stage renal disease (ESRD) reached
epidemic proportions in 2012 with over 600,000 patients being treated. The rates of ESRD …

[HTML][HTML] Hypoxia: The Force that Drives Chronic Kidney Disease

Q Fu, SP Colgan, CS Shelley - Clinical Medicine & Research, 2016 - ncbi.nlm.nih.gov
Abstract In the United States the prevalence of end-stage renal disease (ESRD) reached
epidemic proportions in 2012 with over 600,000 patients being treated. The rates of ESRD …

Hypoxia: The Force that Drives Chronic Kidney Disease.

Q Fu, SP Colgan, CS Shelley - Clinical Medicine & …, 2016 - search.ebscohost.com
Abstract In the United States the prevalence of end-stage renal disease (ESRD) reached
epidemic proportions in 2012 with over 600,000 patients being treated. The rates of ESRD …